Sugi Predict

Sugi Predict / Compounds / SCHEMBL12415325

SCHEMBL12415325

SCHEMBL12415325

Clc1c2ccccc2c(-c2ccc(-c3ccccc3)cc2)c2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.50
▸ MAOA P21397 1/20 0.44
▸ MAOB P27338 1/20 0.44
▸ ACHE P22303 2/20 0.43
▸ ESR2 Q92731 8/20 0.43
▸ ESR1 P03372 7/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ MAPK1 P28482 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ TAAR1 Q96RJ0 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ MMP3 P08254 1/20 0.39
▸ BCL2L1 Q07817 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ ENPP1 P22413 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9971795 0.95 MAOA (0.48) CYP1A2MAOAMAOBACHEESR2
SCHEMBL29242875 0.88 MAOA (0.45) CYP1A2MAOAMAOBESR2ESR1
SCHEMBL27919608 0.87 ALDH1A1 (0.56) CYP1A2ACHEESR2ESR1ALDH1A1
SCHEMBL27367260 0.87 ALDH1A1 (0.56) CYP1A2ACHEESR2ESR1ALDH1A1
SCHEMBL21435740 0.87 ALDH1A1 (0.56) CYP1A2ACHEESR2ESR1ALDH1A1
SCHEMBL21435722 0.87 ALDH1A1 (0.56) CYP1A2ACHEESR2ESR1ALDH1A1
Biphenyl SCHEMBL27607852 0.86 CYP1A2 (0.71) CYP1A2ACHEESR2ESR1ALDH1A1
SCHEMBL29134681 0.86 MAOA (0.47) MAOAMAOBESR2ESR1ALDH1A1
SCHEMBL5448953 0.85 ALDH1A1 (0.53) CYP1A2ACHEESR2ESR1ALDH1A1
SCHEMBL12415335 0.85 ESR2 (0.40) CYP1A2MAOAMAOBACHEESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117999268-A Organic compound and organic electroluminescent element using same 索路思高新材料有限公司 2024-05-07 — — CN disclosed
WO-2019177393-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2019-09-19 — — WO disclosed
US-8283855-B2 Method for synthesis of anthracene derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-10-09 — — US disclosed
US-8283855-B2 Method for synthesis of anthracene derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-10-09 — — US disclosed
US-20110172441-A1 METHOD FOR SYNTHESIS OF ANTHRACENE DERIVATIVE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-07-14 — — US disclosed
US-20110172441-A1 METHOD FOR SYNTHESIS OF ANTHRACENE DERIVATIVE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172441-A1 METHOD FOR SYNTHESIS OF ANTHRACENE DERIVATIVE CYP1A1, AHR, CYP2C9 CYP1A2 8/4885MAOA 276/4885MAOB 298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.